Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.
Clinical trial NCT05123976 · COMPLETED
Trial details
- NCT number
- NCT05123976
- Sponsor
- Joint Stock Company "Farmak"
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2020-11-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.